Related Experiment Video
Updated: Sep 9, 2025
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Blood Eosinophil Stability Predicts Clinical Outcomes in Hospitalized Patients with Acute Exacerbations of COPD
Lujia Guan1, Jiachen Li2, Lirong Liang2
1Department of Respiratory and Critical Care Medicine, Beijing Research Center for Respiratory Infectious Diseases, Beijing Institute of Respiratory Medicine and Beijing Chao Yang Hospital, Capital Medical University, Beijing, People's Republic of China.
Background And Objective:
Blood eosinophil (EOS) levels are considered a potential biomarker for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) management, but the impact of EOS stability during hospitalization on outcomes is unclear. This study examined the relationship between EOS stability and clinical outcomes in these patients.
Methods:
A retrospective analysis was conducted on 2105 AECOPD patients hospitalized at Beijing Chao-Yang Hospital from 2013 to 2022. Patients were classified into four groups according to EOS counts (2%) at admission and discharge: persistent high, decreased, increased, and persistent low. Clinical characteristics and outcomes were compared between EOS stability groups. Multivariable logistic regression was used to evaluate the association between EOS stability and adverse hospital outcomes. Cox regression analysis was performed to assess the risk of AECOPD-related readmission within three years. Receiver operating characteristic (ROC) curves and nomograms were used to evaluate the predictive performance of the models.
Results:
There were 586 (27.8%), 154 (7.3%), 593 (28.2%), and 772 (36.7%) patients in the persistent high, decreased, increased, and persistent low groups, respectively. Multivariable logistic regression analysis showed that the persistent high EOS group had a significantly lower risk of adverse hospital outcomes compared to the persistent low EOS group (aOR: 0.77, 95% CI: 0.59-0.99, P = 0.040). The nomogram developed based on the multivariate model demonstrated good predictive accuracy for adverse hospital outcomes, with an AUC of 0.67, and was well-calibrated. Cox regression analysis revealed that the persistent high EOS group had a higher risk of AECOPD-related readmission within three years compared to the persistent low EOS group (aHR: 1.38, 95% CI: 1.13-1.68, P = 0.001).
Conclusion:
Blood eosinophil stability during hospitalization is associated with AECOPD prognosis and may help guide inpatient treatment and identify patients at higher risk of future readmission.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation